Sarepta Therapeutics Inc
Change company Symbol lookup
Select an option...
SRPT Sarepta Therapeutics Inc
WTW Weight Watchers International Inc
PPIH Perma-Pipe International Holdings Inc
TURN 180 Degree Capital Corp
XTYGX Tortoise Energy Infrastructure Corp
SCCO Southern Copper Corp
TBNK Territorial Bancorp Inc
AAON AAON Inc
SBKJY State Bank of India
CY Cypress Semiconductor Corp
Go

Health Care : Biotechnology | Small Cap GrowthCompany profile

Sarepta Therapeutics, Inc. is a biopharmaceutical company. The Company focuses on the discovery and development of ribose nucleic acid (RNA)-targeted therapeutics for the treatment of rare neuromuscular diseases. It operates through discovering, developing, manufacturing and delivering therapies to patients with Duchenne muscular dystrophy (DMD). It is focused on the development of its disease-modifying DMD drug candidates. It has received accelerated approval for its product, EXONDYS 51, indicated for the treatment of DMD in patients who have a confirmed mutation of the DMD gene that is amenable to exon 51 skipping. EXONDYS 51 is studied in clinical trials under the name of eteplirsen. Its next generation phosphorodiamidate morpholino oligomer (PMO)-based compounds are synthetic compounds that bind to complementary sequences of RNA by standard Watson-Crick nucleobase pairing. Its PMO-based chemistries are peptide conjugated PMO (PPMO), PMO-X and PMOplus.

Closing Price
$61.17
Day's Change
0.00 (0.00%)
Bid
--
Ask
--
B/A Size
--
Day's High
--
Day's Low
--
Volume
(Light)
Volume:
0
10-day average volume:
2,248,144
0
  • Prev Close
    61.17
  • Today's Open
    --
  • Day's Range
    --
  • Avg Vol (10-day)
    2.2M
  • Last (time)
    4:00p ET 01/17/18
  • Last (size)
    1
  • 52-Wk Range
    26.26 - 62.85
    LowHigh
  • (02/13/17 - 01/16/18)
    2.67%
  • 48.4%
  • Market Cap
    4.0B
  • Shares Outstanding
    64.6M
  • -2.04
  • --
  • No dividend
  • Ex-dividend
    No dividend
  • 1.4
  • 81.34
  • (% of float 12/15/17)
    17.04

Latest News

January 17, 2018
2:10 pm ET
PR Newswire
January 14, 2018
7:18 pm ET
MarketWatch
January 08, 2018
6:41 pm ET
Globe Newswire
January 02, 2018
1:30 pm ET
Globe Newswire
December 29, 2017
11:00 pm ET
Globe Newswire
December 27, 2017
1:30 pm ET
Globe Newswire
December 19, 2017
11:30 am ET
PR Newswire
December 05, 2017
1:30 pm ET
Globe Newswire
November 30, 2017
11:30 pm ET
Globe Newswire
November 30, 2017
1:00 pm ET
Globe Newswire
November 21, 2017
1:30 pm ET
MarketWatch
November 10, 2017
2:45 am ET
Globe Newswire
November 08, 2017
11:45 pm ET
Globe Newswire
November 08, 2017
9:43 pm ET
PR Newswire
November 07, 2017
9:15 pm ET
Market Wire
November 07, 2017
1:30 pm ET
Globe Newswire
November 06, 2017
1:30 pm ET
Globe Newswire
November 03, 2017
12:30 pm ET
Globe Newswire
November 01, 2017
12:30 pm ET
Globe Newswire
October 31, 2017
10:30 pm ET
Globe Newswire
October 31, 2017
12:30 pm ET
Globe Newswire
October 25, 2017
8:02 pm ET
Globe Newswire
October 09, 2017
12:30 pm ET
MarketWatch
October 09, 2017
12:22 pm ET
MarketWatch
October 02, 2017
2:25 pm ET
MarketWatch
October 02, 2017
2:06 pm ET
MarketWatch
October 02, 2017
1:28 pm ET
MarketWatch
September 29, 2017
3:36 pm ET
MarketWatch
September 29, 2017
3:28 pm ET
MarketWatch
September 07, 2017
10:55 am ET
MarketWatch
September 06, 2017
5:45 pm ET
MarketWatch
September 06, 2017
3:21 pm ET
MarketWatch
September 06, 2017
11:05 am ET
MarketWatch
September 06, 2017
11:02 am ET
MarketWatch
Go to all current & historical news

Earnings Calendar and Events Data provided by |Terms of Use| © 2018 Wall Street Horizon, Inc.

Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.

Options are not suitable for all investors as the special risks inherent to options trading may expose investors to potentially rapid and substantial losses.
Please read Characteristics and Risks of Standard Options before investing in options.

"Hot" indicates urgent and noteworthy news stories as determined by providers Dow Jones or Benzinga. TD Ameritrade does not select or recommend "hot" stories.

Information and news provided by ,, , Computrade Systems, Inc., , and

Copyright © 2018. All rights reserved.